ALK, ROS1 and EGFR Next-Generation Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer
Oncology in Clinical Practice - Poland
doi 10.5603/ocp.2018.0042
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 26, 2019
Authors
Publisher
VM Media SP. zo.o VM Group SK